Nov 09, 2023 / 09:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the Cue Biopharma third quarter 2023 earnings call. (Operator Instructions) As a reminder, this call is being recorded today, Thursday, November 9, 2023.
I would now like to turn over the conference to Dan Passeri, Chief Executive Officer. Please go ahead.
Dan Passeri - Cue Biopharma, Inc. - CEO
Yeah, thank you. And good afternoon, everyone. As a reminder, this presentation and discussion is being recorded and will be available on our website for the next 30 days. Also be aware that the slides accompanying today's update may be advanced directly by those listening in -- on the call, and we'll notify you of what slide we're on throughout the presentation.
Joining me on today's call is Dr. Anish Suri, our President, Chief Scientific Officer; DR. Matteo Levisetti, our Chief Medical Officer; and Kerri-Ann Millar, our Chief Financial Officer.
As shown on slide number two, the presentation and overview may contain some forward-looking statements. In any forward-looking statement made
Q3 2023 Cue Biopharma Inc Earnings Call and Business Update Transcript
Nov 10, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers